The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lowrance David L since year 2005.
The trader's CIK number is 1408498.
At the time of this reporting, Lowrance David L is the Chief Financial Officer of Adventrx Pharmaceuticals Inc .
(stock ticker symbol ANX).
See this page for all insider trading activities at Adventrx Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-07||SVRA||Adventrx Pharmaceuticals Inc||Buy||2,100||4.75||9,975|
|2014-08-18||M??????||Acucela Inc.||Option Ex||40,500||4.52||183,059|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lowrance David L (Chief Financial Officer of Adventrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.